87 related articles for article (PubMed ID: 7690075)
21. Fludarabine, cytarabine, and granulocyte-colony stimulating factor for the treatment of high risk myelodysplastic syndromes.
Ferrara F; Leoni F; Pinto A; Mirto S; Morra E; Zagonel V; Mele G; Ciolli S; Magrin S; Montillo M
Cancer; 1999 Nov; 86(10):2006-13. PubMed ID: 10570425
[TBL] [Abstract][Full Text] [Related]
22. [Successful induction chemotherapy for childhood RAEB-T with VP-16: a case report].
Tanizawa A; Sonomura T; Wakazono Y; Akiyama Y; Kubota M; Mikawa H
Rinsho Ketsueki; 1989 Jul; 30(7):1052-7. PubMed ID: 2810790
[TBL] [Abstract][Full Text] [Related]
23. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
24. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
25. Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.
Mori T; Aisa Y; Yokoyama A; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Kato J; Watanabe R; Takayama N; Ikeda Y; Okamoto S
Bone Marrow Transplant; 2007 Feb; 39(4):217-21. PubMed ID: 17220902
[TBL] [Abstract][Full Text] [Related]
26. Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
Bilgrami S; Feingold JM; Bona RD; Edwards RL; Khan AM; Rodriguez-Pinero F; Khan IA; Kazierad D; Clive J; Tutschka PJ
Bone Marrow Transplant; 2000 Jan; 25(2):123-30. PubMed ID: 10673668
[TBL] [Abstract][Full Text] [Related]
27. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
[TBL] [Abstract][Full Text] [Related]
28. In vivo mobilization of karyotypically normal peripheral blood progenitor cells in high-risk MDS, secondary or therapy-related acute myelogenous leukaemia.
Carella AM; Dejana A; Lerma E; Podestà M; Benvenuto F; Chimirri F; Parodi C; Sessarego M; Prencipe E; Frassoni F
Br J Haematol; 1996 Oct; 95(1):127-30. PubMed ID: 8857949
[TBL] [Abstract][Full Text] [Related]
29. [Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].
Yamamoto K; Nagata K; Morita Y; Hamaguchi H
Rinsho Ketsueki; 2002 Jun; 43(6):488-92. PubMed ID: 12134707
[TBL] [Abstract][Full Text] [Related]
30. [Continuation of complete remission by oral administration of cytarabine ocfosfate in a patient with M0, who achieved remission by small doses of cytosine arabinoside with G-CSF].
Aoki S; Koyama S; Goto T; Takahashi H; Shibata A
Rinsho Ketsueki; 1995 Jan; 36(1):40-4. PubMed ID: 7536275
[TBL] [Abstract][Full Text] [Related]
31. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.
Alegre A; Tomás JF; Martínez-Chamorro C; Gil-Fernández JJ; Fernández-Villalta MJ; Arranz R; Díaz MA; Granda A; Bernardo MR; Escudero A; López-Lorenzo JL; Fernández-Rañada JM
Bone Marrow Transplant; 1997 Aug; 20(3):211-7. PubMed ID: 9257889
[TBL] [Abstract][Full Text] [Related]
32. Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).
Todeschini G; Tecchio C; Pasini F; Benedetti F; Cantini M; Crippa C; Draisci M; Pizzolo G
Cancer; 2005 Aug; 104(3):555-60. PubMed ID: 15959910
[TBL] [Abstract][Full Text] [Related]
33. [Complete remission in erythroleukemia: induced with low dose Ara-C, consolidated with high dose Ara-C].
Imoto S; Ito M; Nakagawa T
Rinsho Ketsueki; 1990 Dec; 31(12):1945-9. PubMed ID: 2079731
[TBL] [Abstract][Full Text] [Related]
34. [An elderly patient with myelodysplastic syndrome successfully treated with combination of granulocyte-colony stimulating factor and continuous-drip infusion of low-dose cytarabine and etoposide].
Yamada T; Tsurumi H; Hara T; Fukuno K; Goto H; Oyama M; Moriwaki H
Rinsho Ketsueki; 2000 Mar; 41(3):218-21. PubMed ID: 10774251
[TBL] [Abstract][Full Text] [Related]
35. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
Smith RJ; Sweetenham JW
Exp Hematol; 1995 Dec; 23(14):1581-8. PubMed ID: 8542950
[TBL] [Abstract][Full Text] [Related]
36. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
Sawada H; Wake A; Yamasaki Y; Izumi Y
Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
[TBL] [Abstract][Full Text] [Related]
37. [High-dose chemotherapy supported by peripheral blood stem cells to treat intermediate--and high-grade non-Hodgkin's lymphomas].
Ji Y; Ji S; Ju X
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):471-5. PubMed ID: 9387307
[TBL] [Abstract][Full Text] [Related]
38. Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study.
Kikuchi A; Hasegawa D; Ohtsuka Y; Hamamoto K; Kojima S; Okamura J; Nakahata T; Manabe A;
Br J Haematol; 2012 Sep; 158(5):657-61. PubMed ID: 22734597
[TBL] [Abstract][Full Text] [Related]
39. Stable hematopoietic recovery after peripheral blood stem cell transplantation in patients receiving high-dose chemotherapy for advanced germ cell tumors.
Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
Anticancer Res; 2006; 26(6C):4965-8. PubMed ID: 17214371
[TBL] [Abstract][Full Text] [Related]
40. [Effects of low dose Ara-C regimen in acute leukemias and RAEB].
Kohno T; Nagai K; Tsukazaki K; Jinnai I; Tomonaga M; Ichimaru M; Tagawa M
Rinsho Ketsueki; 1989 May; 30(5):638-43. PubMed ID: 2795877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
